What is Saxenda Injection in Canada?
Saxenda Injection, which contains the active ingredient Liraglutide, is an injectable medication approved in Canada for the treatment of obesity in adults. Developed by Novo Nordisk, this medication is only available through a prescription from a licensed healthcare professional. It serves as a valuable tool for individuals aiming to lose weight and adopt a healthier lifestyle.
Where to Purchase Saxenda Injection in Canada
In Canada, Saxenda Injection can be easily purchased through a dedicated website. As part of a comprehensive medical weight loss program, Saxenda may be combined with a personalized nutrition and exercise plan developed by a certified nutrition coach. This multi-faceted approach is designed to enhance the effectiveness of weight loss treatment.
Mechanism of Action
Saxenda works by mimicking the natural hormone GLP-1, which is essential for regulating appetite and digestion. It helps reduce feelings of hunger and increases the sensation of fullness, leading to a decrease in calorie consumption and promoting weight loss. The injection can be self-administered by patients after receiving proper training from their healthcare provider.
Indications for Use
Saxenda is prescribed for specific individuals based on their Body Mass Index (BMI) and overall health profile. It is meant to be used in conjunction with a structured low-calorie diet and increased physical activity. Typically, it is indicated for adults with a BMI of:
– 30 or higher (obese)
– 27 to 29.9 (overweight) if they have at least one weight-related health condition, such as type 2 diabetes, hypertension, or obstructive sleep apnea.
If a patient does not achieve at least 5% weight loss within 12 weeks of using the 3.0 mg daily dose, the prescribing healthcare provider may reconsider the continued use of Saxenda.
Reimbursement Information
In Canada, Saxenda Injection may be eligible for reimbursement for individuals with a BMI of 35 or more who are participating in a lifestyle intervention program. Those with a BMI between 35 and 40 must also have a related health condition to qualify for reimbursement.
Common Side Effects of Saxenda injection in Canada
As with all medications, Saxenda may cause side effects, though not everyone will experience them. Common side effects include headache, nausea, diarrhea, constipation, and vomiting. Typically, these symptoms lessen within days or weeks. For a full list of potential side effects, patients should consult the package insert provided with their Saxenda pen. If any significant side effects occur, it is advisable to consult with a healthcare provider. Feedback on side effects can also be reported through the Netherlands Side Effects Center Lareb.
Dosage and Administration
Patients should follow the dosing schedule outlined by their healthcare provider. The recommended dosage gradually increases from 0.6 mg to a maximum of 3.0 mg:
-Week 1: 0.6 mg once daily
– Week 2: 1.2 mg once daily
– Week 3: 1.8 mg once daily
– Week 4: 2.4 mg once daily
– Week 5: 3.0 mg once daily (maintenance dose)
It is important to not exceed the daily dose of 3.0 mg, and the gradual uptick in dosage helps to minimize nausea as the body adjusts to the medication.
Injection Guidelines
Moreover, Saxenda is administered via a subcutaneous injection, meaning it should be injected under the skin in Canada. Appropriate sites for injection include the front of the thighs, abdomen, or upper arm. Training on the effective use of the pen will be provided by healthcare professionals before its first use.
Storage Recommendations
Before its first use, Saxenda should be kept in a refrigerator at a temperature between 2°C to 8°C. It should not be frozen or placed near the freezer compartment to maintain its effectiveness.
